A 3-year follow-up study of Norethisterone Oenanthate in Nairobi, Kenya.
Mati Jkg
Aggarwal
V P
VP
Fraser
R B
RB
D000349:Africa; D017954:Africa South of the Sahara; D000351:Africa, Eastern; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003906:Developing Countries; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D007267:Injections; D007630:Kenya; D017258:Medroxyprogesterone Acetate; D011446:Prospective Studies; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
Africa; Africa South Of The Sahara; Clinical Research; Contraception; Contraception Continuation; Contraception Failure; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods; Contraceptive Usage; Depo-provera; Developing Countries; Eastern Africa; English Speaking Africa; Evaluation; Family Planning; Injectables; Kenya; Prospective Studies; Research Methodology; Research Report; Studies